Table 2.

Clinical Characteristics of All Patients Discharged From Each Major Acute Care Hospital (≥50 Discharged Patients) and the Prevalence of Antibiotic-resistant Organism Colonization at Nursing Facility Admission, by Discharge Hospital

Characteristic	Hospital 8 (n = 55)	Hospital 10 (n = 101)	Hospital 19 (n = 61)	Hospital 20 (n = 87)	Hospital 26 (n = 90)	Other Hospitals (n = 190)	P Value
Male sex, %	45	43	44	44	36	42	.844
Urinary catheter use in past 30 d, %	26	23	31	33	31	29	.695
Age, y, mean (SD)	71.44 (13.81)	71.71 (12.62)	73.61 (12.96)	77.56 (9.21)	79.8 (10.46)	74.34 (11.88)	< .001
Physical self-maintenance scale, mean (SD)	14.45 (5.06)	14.01 (4.41)	13.9 (4.09)	13.98 (4.13)	15.17 (4.79)	14.28 (4.73)	.467
Length of hospital stay, d, mean (SD)	7.84 (5.61)	6.58 (5.12)	7.9 (5.77)	6.16 (5.3)	6.9 (4.31)	7.52 (9.16)	.478
Charlson comorbidity score, mean (SD)	2.91 (1.89)	3.39 (2.38)	2.84 (1.9)	2.13 (2.2)	2.47 (1.97)	2.23 (1.82)	< .001
Black race, %	96	71	72	0	7	22	< .001
Exposure to 1st/2nd-gen cephalosporins, %	0	5	11	11	9	16	.004
Exposure to 3rd/4th-gen cephalosporins, %	11	18	23	11	13	11	.145
Exposure to glycopeptides, %	4	16	13	9	17	13	.2
MRSA colonization at discharge, %	9	11	13	7	12	14	.662
VREfm colonization at discharge, %	18	14	33	8	23	15	.002
VREfc colonization at discharge, %	5	8	7	6	11	10	.67
CipREc colonization at discharge, %	4	10	5	7	6	4	.452

One-way analysis of variance was used to compare patient characteristics and antibiotic resistant–organism prevalence at different hospitals.

Abbreviations: CipREc, ciprofloxacin-resistant Escherichia coli; MRSA, methicillin-resistant Staphylococcus aureus; SD, standard deviation; VREfc, vancomycin-resistant Enterococcus faecalis; VREfm, vancomycin-resistant Enterococcus faecium.